Background: To investigate the effects of fluids resuscitation on pulmonary expression of aquaporin1 and aquaporin5 in a rat model of uncontrolled hemorrhagic shock and infection.
Introduction
Traumatic injury, often accompanied by hemorrhagic shock (HS), continues to be the most common cause of death for young people, as well as a significant source of morbidity and mortality for all ages [1, 2] .
Infusions of crystalloid and colloid solutions are often the mainstay for the prehospital and inhospital treatments of severe HS. However, it is still a controversy that which would be the better choice for fluid resuscitation after severe HS. The ideal resuscitation fluid would restore the intravascular volume rapidly, reverse the tissue injury effectively and has a beneficial efficacy on mortality [3] . Thus, intensive experiment works are needed to find the more appropriate fluid for resuscitation.The acute lung injury (ALI) or the acute respiratory distress syndrome (ARDS) are the major causes of morbidity and mortality following hemorrhagic shock [4] . Pulmonary edema resulting from injury or infection is one of the pathological conditions of the lung, which is characterized by disrupted fluid transport [5] . However, the exact mechanism responsible for the development of ALI or ARDS remains unclear. Several lines of recent evidence suggest that aquaporins (AQPs) may play a critical role in the pathophysiology of ALI/ARDS. The AQPs are a family of water-selective channels that function to increase plasma membrane water permeability and provide a route for rapid fluid movement [6] . Several known AQPs are expressed in the lung, such as AQP1 and AQP5. AQP1 is expressed in the capillary endothelium and AQP5 is expressed at the apical membrane of alveolar epithelial cells [7] . The observed decrease in permeability in AQP1-knockout mice support a role for AQP1 in the pathophysiology of the lung [8, 9] . In addition, recent studies demonstrated that the expression levels of AQP1 and AQP5 in the lung decreased in viral infection model of pulmonary edema [10, 11] . However, to date, no data is available on the expression of AQPs in the lung in a two-hit model of uncontrolled hemorrhagic shock and infection in rats.Therefore, the purposes of this experiment were (1) to investigate the expression of AQPs in the two-hit model of uncontrolled hemorrhagic shock and infection in rats and (2) to use this model to compare the effects of different fluids resuscitation on ALI and pulmonary expression of AQPs.
Materials and Methods
This study was approved by Animal Care and Use committee of the School of Medicine, Yangzhou University and was in accordance with the National Guidelines for Animal Care and Use. In the experiment, except for some animals that intolerance to the ''two-hit'', and died before the end of the experiment, the other animals all died under deep anesthesia at the end of the experiment by overdose of sodium pentobarbital (150 mg kg 21 , IP). All animals were ultimately killed by excessive anesthetics because we needed to collect the biological samples from the lung tissue of the animals.
Animals and Model
60 Sprague-Dawley rats, weighing 250-290 g, were anesthetized with an intraperitoneal injection of pentobarbital sodium (30 mg/kg). The animals were randomly divided into five groups (n = 12 per group), to receive following treatments: (1) sham operation group (group C), only received cannulation and observation; (2) no fluid resuscitation in the ''prehospital phase'' group (group NF); (3) lactated Ringer's solution group (group LR), resuscitated with lactate Ringer's solution in a 3:1 ratio to the shed blood volume during the ''prehospital phase''; (4) 7.5% hypertonic saline group (group HTS), resuscitated with a bolus dose of 4 ml/ kg [12] of 7.5% hypertonic saline during the ''prehospital phase''; (5)Hydroxylethyl starch group (group HES), resuscitated with Hydroxylethyl starch (Voluven, mean molecular weight 130 kDa; degree of substitution, 0.4, Fresenius Kabi) in a volume equal to the shed blood volume during the ''prehospital phase''.All the resuscitation fluids were given immediately after the tail cut.
Experimental Procedure
A right carotid arterial catheter was placed in rats for continuous hemodynamic monitoring and blood sampling. The mean arterial pressure (MAP) was recorded at baseline (T0), 60 min in prehospital phase (T1), 80 min in prehospital phase (T2), 90 min in prehospital phase (T3) and 60 min inhospital phase (T4), 1 hour in observation phase (T5), 2 h in observation phase (T6), 3.5 h in observation phase (T7). A right jugular venous catheter was placed for administration of resuscitation fluids.Rats were exposed to a two-hit model of uncontrolled HS and infection of three phases [13] :a HS prehospital phase I of 90 min, a resuscitation phase II of 60 min, and an observation phase III of 3.5 h. In phase I, HS was initiated by withdrawal of arterial blood (2 mL of blood per 100 g of body weight), through the right carotid artery catheter until a MAP of 30 mmHg was reached. MAP was maintained at 30-40 mmHg for 60 min by withdrawing or reinfusing the shed blood (kept at 37uC) as required. The shed blood was collected in a glass syringe with heparin (10 IU/mL) and later reinfused during the resuscitation phase. At 60 min of HS, uncontrolled HS was initiated by amputation of 75% of the tail (measured from tip of tail) and followed by mimicked infection by intratracheal administration of lipopolysaccharide (LPS) (E. Coli O55:B5, sigma Chemical, St Louis, MO, USA) 2 mg/kg. During the uncontrolled HS, blood from the tail was collected, measured, and then discarded. Starting at phase I of 60 min, and until phase I of 90 min, animals received different resuscitation fluids according to group assignments. At 90 min, a phase simulating hospital treatment (phase II) began, which lasted for 60 min. The tail stump bleeding was stopped by tail ligation and the tail wound closed. Simultaneously, resuscitation began with the reinfusion of all the blood initially shed. The Phase III was only an observation period with no additional treatments and it lasted for 3.5 h. Throughout the study, all rats breathed spontaneously and a feedback controlled heating system was used to maintain the temperature at about 37uC. Blood samples for the measurement of arterial blood gases were taken before shock (baseline) and at 3.5 h of the phase III. At the end of phase III, the survival rates were recorded. Subsequently, the thorax was opened by a midline thoracotomy and BALF was collected from the left lung through the trachea. The right lung was removed and frozen with liquid nitrogen at a temperature of -180uC for latter assays of AQP1, AQP5, and wet-to-dry lung weight.
Arterial Blood Gas Analysis
An arterial blood sample of 0.25 mL was used to measure plasma lactate, pH, PO2, and base excess (BE) by a Radiometer ABL 625 Blood Gas Analyzer (Copenhagen, Denmark).
Measurement of Wet to Dry Lung Weight and BALF/ Plasma Protein Ratios
The lung tissue was excised from the rats and then weighed to obtain lung ''wet'' weights. The obtained tissues are dried in a 60uC oven with desiccant for 72 hours and reweighed, then the W/D ratio was determined. The total protein contents of BALF and plasma were determined by the Bradford protein assay, thus the BALF to plasma protein ratio was determined. Pulmonary permeability index (PPI) values were expressed with the protein concentration in BALF-to-protein concentration in plasma ratio.
AQP1 and AQP5 Western Blot Analysis
Lung tissues were homogenized with five volumes of lysis buffer containing 1% (vol/vol) NP-40, 0.5% (wt/vol) sodium deoxycholate, and 0.1% (wt/vol) sodium dodecyl sulfate (SDS) in PBS, to which a protease inhibitor, phenylmethylsulfonyl fluoride, 100 mg/ mL, was added. The homogenate was left on ice for 30 min before centrifugation. Protein content was estimated and aliquots of 30 mg of homogenate protein were diluted with sample buffer containing 125 mM Tris, 20% (wt/vol) glycerol, and 4% (wt/vol) SDS and separated on 10% (wt/vol) polyacrylamide gels with 0.1% (vol/vol) SDS. Twenty micrograms of protein from the supernatant of each sample was loaded onto a 10% polyacrylamide gel, and transferred to nitrocellulose membranes by the electrophoresis. The membrane was blocked in 3% TBS (Tris Buffered Saline ) solution for 1 h at room temperature and probed with 1:400 dilution of rabbit anti-aquaporin1(AQP1) and with 1:300 dilution of rabbit anti-aquaporin5(AQP5) (Santa Cruz Biotechnology Inc, Santa Cruz, CA) in TBS overnight at 4uC. Then the membrane was washed completely and probed by horseradish peroxidase-conjugated goat anti-rabbit IgG at 37uC for 1 h. Protein bands were quantified using the Kodak Digital Science Image Analysis Software (Eastman Kodak, Rochester, NY).
Lung Histology
Inflation-fixed lungs were washed in phosphate-buffered saline (PBS) three times and bisected for paraffin embedding. Paraffinembedded lungs were sectioned at 3 mm and stained with hematoxylin and eosin (H&E) for morphologic analysis.
Statistical Analyses
The results are expressed as means 6 standard deviation (SD). With SPSS 13.0 (SPSS Institute, Chicago, IL, USA), one way analysis of variance (ANOVA) followed by the Bonferroni post hoc test was used to compare mean values from five groups. The comparisons of survival rate among groups were made with Kaplan-Meier methods. Differences were considered significant at values of P,0.05.
Results

Variation of Mean Arterial Pressure (MAP)
When compared with group NF, the three resuscitation groups resulted in a significantly greater overall increase in MAP (p,0.05) at T2 and T3 time points. However, the groups HTS and HES could restore MAP for a longer time than group LR. The group HTS could not restore the MAP at 2 hours (T6) and 3.5 hours (T7) in the observation phase, while the group HES can restore the MAP almost throughout the experiment (p,0.05) ( Table 1) .
Arterial Blood Gas Analysis
There was no obvious differences in the results of the arterial blood gases analysis at baseline among the five groups (data not show). When compared with group C, four treatment groups resulted in significantly greater abnormity in Lactate, pH, PaO2, HCO3-, and base excess (p,0.05) at the end of the experiment (Table 2 ). However, the arterial blood gases were not different between groups NF and LR (p.0.05), and were significantly better in group HES, when compared with the groups NF and LR (p,0.05). The arterial blood gases of group HTS were also better than group NF, but there was no difference in the Lactate level and base excess when compared with group LR. The blood lactate concentration followed the sequence: group NF. group LR. group HTS. group HES (Table 2 ).
Wet to Dry Lung Weight Ratio, BALF and BALF/Plasma Protein Ratio
The W/D ratio, BALF Pro and PPI were all significantly increased in the four treatment groups (p,0.05), but there was no difference between groups NF and LR (p . 0.05). Groups HTS and HES significantly reduced the W/D ratio and PPI compared with the other two treatment groups (p,0.05). Meanwhile, group HES had the lowest amplitude in W/D ratio, BALF Pro and PPI among the treatment groups (Table 3) .
Analysis for AQP1, AQP5 Expressions in Lung Tissues
The AQP1 and AQP5 expressions were significantly decreased in four treatment groups in comparison to group C (p,0.05). There were no significant differences in AQP1 and AQP5 expression between groups NF and LR. The groups HES and HTS attenuated the HS-induced decreased pulmonary expression of AQP1 and AQP5 after the ''two-hit''. Both the pulmonary expressions of AQP5 and AQP1 was much higher in group HES than groups NF and LR (P,0.05). However, group HTS only showed an obvious increase in AQP5 expression when compared to groups NF and LR (Fig. 1, Fig. 2 ).
Histopathological Studies
The pathological changes of lung were examined with light microscope. No inflammatory change was observed in group C (Fig. 3a) , and the lung appeared to remain intact. However, a mass of inflammatory cells infiltrated and migrated into the alveolar spaces and around the vessels, the alveolar wall thickened and showed destructive changes in groups NF and LR ( Fig. 3b and 3c ). These observations of lung injury seen in the two groups above were obviously attenuated in groups HTS and HES, whichwere manifested by less alveolar septal thickening, less inflammatory cells infiltration, and less alveolar congestion ( Fig. 3d and 3e) .
The Survival Rate of Rats after Observation Phase III
At the end, the survival rates of rats were 100%, 60.3%, 75%, 91.7%, and 91.7%, respectively in group C, group NF, group LR, group HTS and group HES. The survival rates of groups HES and HS were significantly enhanced, when compared to groups NF and LR.
Discussion
ALI is characterized by increased permeability of the alveolar capillary barrier, which allows an influx of protein-rich fluid into the air spaces, causing pulmonary edema [14, 15] . Several lines of evidence indicates that AQPs may be important in physiological and pathophysiological processes in the lung [16] . They provide a major pathway for osmotically driven water movement across epithelial and microvascular barriers in the lung. The fluid movement is significantly reduced, 10-fold by deletion of AQP1 or AQP5 and reduced even more by deletion of AQP1 and AQP5 together [9] . Additionally, in aged rats, the reduced lung water transport rate was associated with the downward regulation of AQP1 and AQP5 [17] .Our present study showed that there was significantly decreased expression of AQP1 and AQP5 in the rat lungs after ''two-hit'' model, which was consistent with the increased W/D ratio, as well as the obvious histological alterations. Previous studies suggested that the decrease of AQP1 may play a compensatory role after the lung injury. Alternatively, a decrease in both AQP1 and AQP5 may contribute to edema by essentially reducing the transcellular rate of removal of excess water, thereby effectively trapping water in the alveolar and interstitial spaces.These changes in AQP expressions either may represent a response to inflammation associated pulmonary edema or may be causal in the formation of pulmonary edema. HS is a major cause of death in the setting of trauma. Infusion of crystalloid and colloid solutions is often the mainstay for the prehospital and inhospital treatment of severe HS. However, there is still considerable controversy about which fluid is better for restoring intravascular volume rapidly, reversing tissue injury effectively, and having a beneficial efficacy on mortality. Previous studies [18] [19] [20] [21] supported more evidence of the harmful effects of large-volume Ringer's lactate solution, including initiation of inflammatory cascade, neutrophil activity, as well as increased mortality. HES130/0.4, as a new colloid solution, has been used extensively. Some researchers demonstrated that HES 130/0.4 significantly attenuated neutrophil recruitment and subsequent ALI by decreasing cytokines and nuclear factor-kB activation [22] . Our present study illustrated that, in a rat model of uncontrolled HS and infection, resuscitation with HES 130/0.4 significantly attenuated the HS-induced decreased expression of AQP1 and AQP5 in the lung tissues. Concomitantly, the W/D ratio and PPI, which are used as indicators of pulmonary microvascular permeability, decreased significantly in group HES. Therefore, it is considered that the protective effects of HES 130/0.4 on endothelial barrier dysfunction and high epithelial permeability after uncontrolled HS and infection, to some extent, in part by upregulating the expression of AQP1 and AQP5.
It is well established that HS triggers the immune system and increases inflammation [23] , and neutrophil activation [24] . Thus, it is generally believed that HS contributes to the pathogenesis of ARDS or ALI. In our study, serious ALI was induced by the twohit model, which was confirmed by the histological observations. When compared to the groups NF and LR, the protective effects of HES and HTS were also evident by arterial blood gas analysis and histologic examinations of the lung, which showed that HSinduced interstitial edema and neutrophil infiltration were further improved by HTS, and especially by HES resuscitations. Thus, the two groups above would have higher survival rates of rats. However, some previous studies have demonstrated that HES may be associated with excess mortality in critically ill patients [25, 26] . It seems to be contradictory to our experimental results. The probable reasons for the differeces has been analysed as follows. (1) New data indicate that mortality rates may be increased after high cumulative doses of HES infusion [27, 28] , and in our experiment, HES 130/0.4 was given only in a volume equal to the shed blood. (2) HES safety studies should be large-scale studied in patients at risk with acute need for volume therapy, and with long enough study periods to detect differences in mortality and morbidity. However, the observation time in our study was only 3.5 h, which was not too short. (3) previous clinical studies usually used older HES preparations, such as HES 200/0.5, while in our experiment, HES 130/0.4 was always used as a third -generation resuscitation fluid. Previous study [29] demonstrated that HES 130/0.4 is safer than older HES preparations, because of its different pharmacokinetic properties.
Additionally, upregulated expressions of AQPs were found in groups HTS and HES when compared with groups LR and NF, and were assumed to be one of the possible mechanisms for preventing lung injury in the two-hit model. However, the exact mechanisms responsible for upregulating the expression of AQPs in groups HTS and HES are currently unknown. Hoffert et al also found that when in the hypertonic solutions, the expression of AQP5 promoted in the lung epithelial cells of rat [30] . Previous studies confirmed that the HES 130/0.4 significantly attenuated inflammation and subsequent ALI by decreasing TNF-a and other cytokines activation in a rat sepsis model [31, 32] . The decrease of TNF-a may induce direct promotion of AQPs [33] . Additionally, Towne et al demonstrated that in the lung epithelial cells treated with TNF-a, the expression of AQP5 decreased to 50% of the normal level [34] . Thus, we considered that the decrease of TNF-a treated with HES may induce the upregulation of AQPs.
The experiment also made a comparison with the HES and HTS, and found that HES was more effective than HTS in preventing ALI in the two-hit model. The severity of histological lung damage, pulmonary microvascular permeability (W/D) and plasma lactate, however, was much greater in group HTS than in group HES. There are some possible explanations. First, from our study, the expression of AQP1 was much higher in group HES than group HTS, and the HTS resuscitation could not upregulate the expression of AQP1 in comparison to groups LR and NF. Previous studies demonstrated the reduced lung water transport rate was associated with the downward regulation of AQP1 [9] . Second, of particular note, inflammatory response after the shock is considered to be a key step leading to tissue damage, and resuscitation with HES was more effective in anti inflammation [35] .
Our experimental protocol has several limitations. First, the observed period of our study was limited to 3.5 h. It was insufficient to evaluate the long-term effects of different resuscitation fluids on HS-induced ALI. Further studies are required to assess whether HES can attenuate HS-induced ALI in a longer observation time. The other limitation was that the study did not determine the widespread signaling mechanisms, which are responsible for decreasing and regulating the expression of AQPs after the two-hit model. Clearly, intensive experimental efforts are needed to investigate the exact signaling mechanisms above.
Conclusion
The current experiment showed that in a rat two-hit model of hemorrhagic shock and infection, the decreased expressions of AQP1 and AQP5 may play an important role in acute lung injury. The altered expression was consistent with the severity of pulmonary edema. The fluid resuscitations with hydroxyethyl starch may be the better choice for preventing ALI after severe HS and infection, in part by up-regulating the expressions of AQP1 and AQP5.
